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Epicatechin gallate, a naturally
occurring polyphenol, alters the
course of infection with
β-lactam-resistant Staphylococcus
aureus in the zebrafish embryo
Christina S. Stevens, Helena Rosado, Robert J. Harvey and Peter W. Taylor*
UCL School of Pharmacy, University College London, London, UK
(-)-epicatechin gallate (ECg) substantially modifies the properties of Staphylococcus
aureus and reversibly abrogates β-lactam resistance in methicillin/oxacillin resistant
(MRSA) isolates. We have determined the capacity of ECg to alter the course of
infection in zebrafish embryos challenged with epidemic clinical isolate EMRSA-16. At
30 h post fertilization (hpf), embryos were infected by injection of 1–5 × 103 colony
forming units (CFU) of EMRSA-16 into the circulation valley or yolk sac. Infection by
yolk sac injection was lethal with a challenge dose above 3 × 103 CFU, with no
survivors at 70 hpf. In contrast, survival at 70 hpf after injection into the circulation was
83 and 44% following challenge with 3 × 103 and 1–5 × 103 CFU, respectively. No
significant increases in survival were noted when infected embryos were maintained
in medium containing 12.5–100 μg/mL ECg with or without 4 or 16 μg/mL oxacillin.
However, when EMRSA-16 was grown in medium containing 12.5 μg/mL ECg and
the bacteria used to infect embryos by either the circulation valley or yolk sac, there
were significant increases in embryo survival in both the presence and absence of
oxacillin. ECg-modified and unmodified, GFP-transformed EMRSA-16 bacteria were
visualized within phagocytic cells in the circulation and yolk sac; pre-treatment with ECg
also significantly increased induction of the respiratory burst and suppressed increases
in IL-1β expression typical of infection with untreated EMRSA-16. We conclude that
exposure to ECg prior to infection reduces the lethality of EMRSA-16, renders cells
more susceptible to elimination by immune processes and compromises their capacity
to establish an inflammatory response in comparison to non-exposed bacteria.
Keywords: epicatechin gallate, tea catechins, MRSA, Staphylococcus aureus, zebrafish embryo infection,
antibacterial activity, respiratory burst
Introduction
Staphylococcus aureus is a highly successful opportunistic pathogen: it is a common component
of the microbiota of the upper respiratory tract and skin (Foster, 2004) but may also
cause a variety of nosocomial and community-acquired infections, ranging from minor skin
conditions to life-threatening diseases such as endocarditis, septicemia and toxic shock syndrome
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(Plata et al., 2009; Thwaites et al., 2011). S. aureus also has
the capacity to accumulate antibiotic resistance genes. Infections
due to multi-drug-resistant forms such as methicillin-resistant
S. aureus (MRSA) can occur in epidemic waves that are initiated
by one or a few successful clones and can spread rapidly among
hospitalized patients and healthy individuals in the community
alike (Chambers and DeLeo, 2009). MRSA isolates are invariably
resistant to all β-lactam agents due to the acquisition of mecA or
its homolog mecC. These genes encode the low-aﬃnity penicillin
binding protein (PBP) 2a, a transpeptidase that forms a functional
complex with PBP2 to enable peptidoglycan synthesis after
β-lactam acylation of native, membrane-localized PBPs (Fuda
et al., 2005; Paterson et al., 2014). MRSA infections are associated
with extended hospital stay, high treatment costs, prolonged
illness and adverse mortality rates (Datta and Huang, 2008;
Anderson et al., 2009) and new treatments and prophylactic
measures are urgently needed. Novel treatment options that
reduce the rate of emergence of drug resistance would be
particularly welcome.
The naturally occurring, abundant polyphenol (-)-epicatechin
gallate (ECg) has the capacity to abrogate β-lactam resistance
in MRSA, reduce the secretion of virulence eﬀectors such
as toxins and tissue-degrading enzymes, and prevent the
formation of bioﬁlms (Taylor et al., 2005; Taylor, 2013),
making it potentially useful for the control of diﬃcult-to-treat
staphylococcal infections. In common with catechins and other
catechin gallates, ECg shows a strong tendency to partition into
lipid bilayers, including model lipid bilayers comprising single
phospholipid species and more complex biological membranes
such as the staphylococcal cytoplasmic membrane (CM) (Caturla
et al., 2003; Bernal et al., 2010). ECg penetrates deep into the
hydrophobic core of the lipid palisade of the staphylococcal
bilayer to induce a comprehensive reconﬁguration of membrane
architecture (Palacios et al., 2014; Rosado et al., 2015), providing
a suboptimal environment for the cell wall biosynthetic and
cell division machineries. Thus, intercalation of ECg into
the staphylococcal CM leads to increased cell wall thickness
(Stapleton et al., 2007) and increases in the net negative charge
at the bacterial surface due to reductions in D-alanylation
of wall teichoic acid (Bernal et al., 2009) and lysylation of
phosphatidylglycerol head groups (Bernal et al., 2010; Rosado
et al., 2015). Most importantly, ECg intercalation delocalizes
PBP2 from the septal site of cell division (Bernal et al.,
2010) and disrupts the functional integrity of the cell division
assemblage, the divisome (Paulin et al., 2014). These latter eﬀects
account for the reversible loss of β-lactam resistance induced by
ECg.
The oral bioavailability of naturally occurring catechin gallates
in humans and other animals is low (Yashin et al., 2012), they
are poorly absorbed from the intestinal tract and are rapidly
metabolized to inactive products due to the presence of ester
bonds susceptible to enzymatic hydrolysis (Kohri et al., 2001).
Further, they appear in the blood circulation mainly in conjugate
form after glucuronidation, sulfation, or methylation (Yang et al.,
2008). They also display chemical instability (Zhu et al., 1997).
Degradation of ECg in biological milieu can be prevented by
replacement of a hydrolytically susceptible ester linkage with
a stable amide whilst maintaining the natural stereochemistry
(Anderson et al., 2005a) and membrane penetration can be
enhanced by removal of hydroxyl functions on one of the
two ECg pharmacophores (Anderson et al., 2005b, 2011).
However, even after optimization of the routes to catechin
stereochemistry (Anderson et al., 2014), chemical synthesis of
these catechin analogs is suﬃciently complex and low-yielding
for the generation of adequate quantities of material to enable
proﬁling in small animal models of infection to be unrealistic.
We have therefore adapted a model of staphylococcal infection in
the zebraﬁsh embryo (Prajsnar et al., 2008) to gain insights into
the capacity of ECg to alter the in vivo course of infection with
MRSA.
Zebraﬁsh are small tropical freshwater ﬁsh native to
India, Pakistan, and Bhutan and have provided a powerful
model for the study of developmental biology and disease
(Goldsmith and Jobin, 2012). External fertilization, ex utero
development and the transparency of zebraﬁsh embryos enables
the details of embryological processes and development to
be investigated using a light microscope, in contrast to
the mouse, in which this stage occurs in utero (Stuart
et al., 1990). The transparency of zebraﬁsh embryos also
allows for ﬂuorescent dyes to be observed in live embryos
by microscopy (Herbomel et al., 1999). Embryos possess
functional innate immunity and have facilitated the dissection
of non-speciﬁc host-pathogen interactions during staphylococcal
infection (Prajsnar et al., 2008). Here we show that pre-
treatment with ECg reduces the lethality of MRSA for zebraﬁsh
embryos in both the presence and absence of the β-lactam
oxacillin.
Materials and Methods
Bacteria
Epidemic MRSA strain EMRSA-16 was isolated from a clinical
sample obtained at the Royal Free Hospital, London. EMRSA-
16 expressing Green Fluorescent Protein (EMRSA16-GFP) was
obtained by transformation of electro-competent S. aureus
EMRSA-16 cells with plasmid pSB2035 (P3 ampliﬁed by PCR
from S. aureus 8325-4, exchanged with PxylA from pSB2030,
Apr Cmr; Qazi et al., 2001) DNA extracted from S. aureus
SJF1219, kindly provided by Professor Simon Foster (Sheﬃeld
University, UK). Bacteria were grown in Mueller Hinton (MH)
broth at 37◦C to mid-logarithmic phase (OD600 0.7) with
agitation in an orbital incubator (200 orbits/min) and collected
by centrifugation. Bacterial pellets were suspended in phosphate
buﬀered saline (PBS) containing 0.05% sterile phenol red (Sigma–
Aldrich, Gillingham, Dorset, UK), or PBS alone for ﬂuorescence
assays. Both were ﬁltered through a 0.22 μm Millex ﬁlter
(Millipore, Carrigtwohill, Ireland). Bacteria were enumerated
by serial dilution and plating on to MH agar or MH agar
containing 20 μg/mL chloramphenicol (for EMRSA16-GFP).
Growth medium was supplemented as required with ECg,
provided by Mitsui Norin Co., Tokyo, Japan. ECg was dissolved
in 50% v/v ethanol and added to the bacterial culture to a ﬁnal
concentration of 12.5 μg/mL as required.
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Zebrafish Husbandry
Wildtype AB/TULF zebraﬁsh were maintained at the University
College London zebraﬁsh facility (http://www.ucl.ac.uk/
zebrafish-group) in a multi-rack recirculating system from
Aquatic Habitat (Apopka, FL, USA) at an air temperature of
24◦C, water temperature of 28.5◦C and pH of 7.6. Adult zebraﬁsh
were maintained in 10 L tanks, containing approximately 9 L
of ﬁltered, recirculated tap water, with a maximum density of
30 ﬁsh. Fish were fed three times daily with a mixture of brine
shrimp, krill, and hikari high protein pellets and were daily
monitored for signs of disease. Zebraﬁsh were maintained on
a 14 h light and 10 h dark photoperiod and embryos collected
within 1 h of the onset of the light cycle. Embryos were incubated
at 28.5◦C in E3 medium according to Nüsslein-Volhard and
Dahm (2002).
Microinjection of Zebrafish Embryos
TW100-4 borosilicate glass capillaries [World Precision
Instruments (WPI), Sarasota, FL, USA] were pulled in a Model
P-97 Flaming/Brown Micropipette Puller (Sutter Instruments
Inc, Novato, CA, USA). The injection volume was determined
by expansion upon injection of bacterial suspension into oil
on a graticule. Embryos were mechanically dechorionated 24 h
post fertilization (hpf) using jewelers’ forceps and anesthetized
by submersion in 0.02% (w/v) buﬀered (pH 7.0) tricaine.
Embryos were embedded in 3% (w/v) methylcellulose and
injected individually with 1–2 nL of bacterial suspension into
the circulation valley or the yolk sac using a rig consisting of
a pneumatic micropump, microinjector, micromanipulator,
injection arm (all WPI), and optical dissecting microscope.
Infected embryos were carefully washed and each placed in
one well of a 96-well microtiter dish and incubated at 28.5◦C.
The bacterial suspension was prepared with phenol red in
order to visualize and conﬁrm the site of injection and volumes
injected into PBS and viable counts performed to determine the
precise injected inoculum. In some experiments, embryos were
incubated with ECg and oxacillin. The concentrations of these
compounds in the E3 incubation mixture were determined by
HPLC (1260 Inﬁnity system, Agilent Technologies, Wokingham,
UK) using a Synergi Polar RP 250 mm × 4.6 mm, 4 mm column
(Phenomenex, Macclesﬁeld, UK). The mobile phase, optimized
for clear separation of components of interest, contained 25%
acetonitrile in 0.1% triﬂuoroacetic acid; an injection volume
of 10 μL and a ﬂow rate of 1 mL/min with UV detection
(280 nm) were employed. Embryos up to 120 hpf obtain
nutrients exclusively from the yolk sac and do not fall under
U.K. or European regulatory frameworks dealing with animal
experimentation.
Embryo Mortality and Bacterial Enumeration
Following EMRSA-16 Infection
EMRSA-16 [1–5 × 103 colony forming units (CFU)] was injected
into the circulation valley or yolk sac of groups of ∼30 zebraﬁsh
embryos at 30 hpf. Control embryos were either injected with
0.05% phenol red in PBS or heat-killed (80◦C for 30 min)
EMRSA-16. Embryos were placed individually into wells of a
96-well microtiter dish after injection of bacteria, incubated at
28.5◦C and inspected for survival at regular intervals up to 70 h
post infection (hpi). Survival was determined by microscopic
observation of the heartbeat; deaths were recorded at each
time point. At regular intervals up to 70 hpi, live and dead
embryos were placed individually into 100 μL of E3 medium,
homogenized with a micropestle, serially diluted and plated on to
MH agar to enumerate EMRSA-16. As embryos had developed a
microbiota by 30 hpf (unpublished; and see Roeselers et al., 2011),
50μg/mL kanamycin was incorporated into the growth medium;
EMRSA-16 is kanamycin-resistant.
Microscopy
EMRSA-16-GFP was visualized within anesthetized (0.02%
tricane) embryos using a Zeiss LSM 710 confocal microscope
(Carl Zeiss, Oberkochen, Germany) ﬁtted with a 25mW 488 nm
Argon ion laser.
Determination of Respiratory Burst
Respiratory burst was determined essentially according to
Hermann et al. (2004). Individuals from groups of ten embryos
were placed in wells of a 96-well microtiter dish with 100 μL
E3 medium and the production of reative oxygen species
(ROS) stimulated with 400 ng/mL phorbol mysristate acetate
(PMA; in DMSO) in the presence of 1 μg/mL of the
non-ﬂuorescent dye 2′,7′-dihydrodichloroﬂuorescein diacetate
(H2DCFDA; Invitrogen, Paisley, UK). Oxidation of H2DCFDA
produces the ﬂuorescent product dichloroﬂuorescein, which was
detected by excitation at 485 nm and emission at 520 nm. Wells
containing embryos in suspension were normalized to wells
containing only suspension medium and data normalized to
background ﬂuorescence.
Analysis of Fluorescent Cell Populations by
Flow Cytometry
Embryo cell blood cell populations were examined by ﬂow
cytometry. Groups of one hundred embryos were anesthetized,
collected and as much E3 medium as possible removed. Isotonic
calcium-free Ringer’s solution (100 μL) was added, yolks were
removed by mixing with a P200 pipette and the suspension
incubated for 5 min at room temperature; 2 mL of 0.05% trypsin
was then added, the mixture incubated for 30 min at 30◦C and
embryos dissociated by pipetting at regular intervals (every 5–
10 min) with a P1000 pipette. This lysis step was terminated by
addition of 200 μL of 2 mM CaCl2 and 100 μL of 1% w/v bovine
serum albumin. The cell suspension was ﬁltered through a 40μm
cell strainer to ensure that it would not block the ﬂow cytometer
and centrifuged at 300 g for 7 min at 20◦C. The supernatant
was removed and centrifuged at 5000 g for 10 min. Pellets
from both centrifugation steps were suspended in 1 mL of PBS,
combined and incubated with 10μg/mL of propidium iodide (PI)
in the dark for 15 min (PI is membrane impermeant, excluded
from viable cells, and identiﬁes dead cells; absorption maximum
535 nm, emission maximum 617 nm). Cells were analyzed using
MACSQuant R© Analyzer (Milteni Biotech, Bergisch Gladbach,
Germany); 20 000 events were detected in an uptake volume of
200μL. Forward scatter was set to 300 V and side scatter to 330 V.
All experiments were undertaken ten times.
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Quantitative Real-time PCR (qRT-PCR)
Transcription of genes encoding β-actin, IL-1β, and TNF-α
was determined by qRT-PCR, essentially as described previously
(Birchenough et al., 2013) using the following forward and
reverse primers: β-actin, ATG GAT GAG GAA ATC GCT G &
ATGCCAACCATCACTCCCTG; IL-1β, CGCCCTGAACAG
AAT GAA GCA C & AAG ACG GCA CTG AAT CCA CCA C;
TNF-α, GGG CAA TCA ACA AGA TGG AAG & GCA GCT
GAT GTG CAA AGA CAC.
Results
EMRSA-16 Infection of Zebrafish Embryos
EMRSA-16 cells were injected into the yolk sac and circulation
valley at 30 hpf, as established by Prajsnar et al. (2008).
Survival of embryos infected by the circulation valley was
directly related to the number of injected bacteria (Figure 1A)
as determined by product limit estimation (Kaplan and Meier,
1958). Death occurred earlier in embryos infected with 3 × 103
and 5 × 103 CFU of EMRSA-16 than in embryos infected with
1 × 103 and 2 × 103 CFU. At 70 hpi 95% of embryos infected
with1 × 103 CFU survived, compared with 87% infected with
2 × 103, 83% with 3 × 103 and 44% with 5 × 103 CFU. All
embryos injected with the same volume of 0.05% phenol red
in PBS or heat-killed EMRSA-16 survived (data not shown).
A similar trend was evident when EMRSA-16 was injected into
the yolk, with survival decreasing in a dose-dependent manner
(Figure 1B). Deaths were recorded in each infected group at
17 hpi and a subsequent decrease in survival at each time point
was observed. A substantial decrease in survival was detected
at 43 hpi in embryos infected with 2 × 103, 3 × 103, and
5 × 103 CFU. After 70 hpi, 54% of embryos infected with 1× 103
and 50% with 2 × 103 CFU survived. However, no embryos
survived in the groups infected with 3 × 103 or 5 × 103 CFU.
To determine the extent of EMRSA-16 proliferation following
infection, homogenates of live and dead zebraﬁsh embryos were
enumerated by serial dilution and subsequent cultivation on MH
agar containing kanamycin. The size of the infecting dose selected
for these experiments reﬂected the diﬀerences in the dose-
dependent lethal eﬀect between yolk-infected and circulation-
infected embryos. With both routes of infection, the bacterial
bioburden tended to increase over time. Injection of 5× 103 CFU
into the circulation valley indicated that in some, but not all,
embryos there was a 1-2-log increase in viable bacteria over
a 70 hpi period (Figure 1C). In some embryos, a decrease in
bacterial load was evident, in all probability reﬂecting the capacity
of a proportion of infected embryos to recover. There was clear
FIGURE 1 | Survival of zebrafish embryos following injection at 30 h post fertilization (hpf) with EMRSA-16 bacteria into the circulation valley (A) or
yolk sac (B). n = 21 ± 1 in each group for (A), n = 22 ± 2 for (B). The number of bacteria injected in a volume of 1–2 nl ranged from 1 × 103 to 5 × 103 colony
forming unit (CFU), as indicated. The staphylococcal bioburden in embryos infected by the circulation valley at 30 hpf with 5 × 103 CFU is shown in (C) and by the
yolk sac with 2 × 103 CFU in (D). n = 60 for each group.
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evidence of bacterial proliferation in all embryos that died as
a result of infection. The bacterial load was particularly widely
distributed at 43 hpi, with mean counts from live embryos
ranging from 5.75 × 102 to 2.15 × 105 CFU. Deaths began to
occur at 43 hpi and were evident at each subsequent time point.
A mean of 9.8 × 105 CFU was detected in dead embryos at
70 hpi. A large number of dead ﬁsh were identiﬁed at 70 hpi,
although some embryos were alive at this time point. The lethal
eﬀect was more evident when EMRSA-16 was injected into the
yolk sac and temporal aspects of bacterial load were therefore
examined following administration of 2 × 103 CFU (Figure 1D).
The bioburden increased rapidly over the ﬁrst 30 hpi and deaths
began to appear at 43 hpi. The mean number cultured from dead
embryos was 2.6 × 106 CFU at 43 hpi compared to a mean from
live embryos of 2.2 × 106 CFU. By 70 hpi, a large number of
ﬁsh had died, with a mean EMRSA-16 burden of 2.8 × 106 CFU.
In this representative experiment only three live ﬁsh remained at
this time point.
Impact of ECg and Oxacillin on Zebrafish
Embryo Survival
Growth in liquid medium containing ECg has a signiﬁcant,
reversible impact on the minimum inhibitory concentration
(MIC) of β-lactam antibiotics against EMRSA-16 and other
resistant strains of S. aureus (Stapleton et al., 2004). For
example, after 4 h growth in 12.5 μg/mL of ECg, the MIC
of EMRSA-16 for oxacillin is reduced from 512 to 1 μg/mL
(Rosado et al., 2015). We therefore investigated the impact of
exposure to ECg alone and ECg in combination with oxacillin
on the survival of 30 hpf embryos; the concentrations of
oxacillin employed reﬂected those that were eﬃcacious following
conversion of EMRSA-16 to phenotypic susceptibility by ECg in
vitro. No deaths or deformities were observed when embryos
were exposed to ECg over a range of 12.5–100 μg/mL or to
oxacillin over 4–300 μg/mL (data not shown). EMRSA-16 cells
were injected into the circulation valley (5 × 103 CFU) or
yolk sac (3 × 103 CFU) of each member of groups of 20
embryos and each embryo placed in individual wells containing
12.5, 50, or 100 μg/mL of ECg without oxacillin or with 4 or
16 μg/mL of the antibiotic. No signiﬁcant increases in survival
were found in the presence of ECg alone or in combination
with oxacillin at any concentration (all P > 0.05; log rank test)
regardless of the site of injection (data not shown). Incubation
of 30 hpf embryos infected by the circulation valley or yolk sac
with chloramphenicol (10 μg/mL), erythromycin (10 μg/mL),
kanamycin (100 μg/mL), or vancomycin (200 μg/mL) in the
absence of ECg failed to increase embryo survival.
To determine if lack of eﬃcacy of ECg was due to a failure
of uptake of the polyphenol by the ﬁsh, uninfected embryos
(untreated and PBS sham-injected) were incubated in E3medium
containing 37.5 μg/mL ECg and 12 μg/mL oxacillin, the samples
removed and the concentrations of ECg and oxacillin in the
medium quantiﬁed by HPLC. No components of E3 medium
masked peaks attributable to the test substances (data not shown).
Each group of 150 embryos was incubated in a single petri
dish. Representative data is shown in Figure 2. There were
large, signiﬁcant reductions in the concentrations of both ECg
and oxacillin in the presence of pooled embryos. A signiﬁcant
decrease in ECg concentration was found after 17 h incubation
with untreated embryos and a smaller but signiﬁcant eﬀect
at this time point was evident with sham-injecteded embryos
(Figure 2A). At 70 h, less than 5% of the initial concentration
of ECg was detected in E3 medium. There were signiﬁcant
reductions in the oxacillin concentration in solution after 17–26 h
incubation and the concentrations continued to decline over the
70 h incubation period. Up to 50 hpi, the oxacillin concentration
declined more rapidly with untreated embryos in comparison to
sham-injected ﬁsh (Figure 2B).
To obtain evidence that MRSA cells modiﬁed by exposure
to ECg are impaired with regard to their capacity to cause
FIGURE 2 | Uptake of epicatechin gallate (ECg) and oxacillin by uninfected 30 hpf zebrafish embryos incubated at 28.5◦C in E3 medium. (A) Uptake of
ECg: , control, E3 medium containing 37.5 μg/mL ECg and 12 μg/mL oxacillin, no embryos; , untreated embryos in E3 medium containing 37.5 μg/mL ECg
and 12 μg/mL oxacillin; , sham treated (PBS) embryos in E3 medium containing 37.5 μg/mL ECg and 12 μg/mL oxacillin. (n = 150 per group) (B), uptake of
oxacillin: symbols as for (A); n = 150 per group. Each concentration determined by HPLC on five occasions; mean ± SD.
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lethal infection, we grew EMRSA-16 to mid-logarithmic phase
in MH broth supplemented with 12.5 μg/mL ECg and infected
30 hpf embryos by the circulation valley (Figure 3A) or yolk
sac (Figure 3B) with 3 × 103 CFU of ECg-modiﬁed bacteria;
infected embryos were then incubated in E3 medium with
and without oxacillin (4 μg/mL) supplementation. For both
injection sites, ECg-modiﬁed bacteria were signiﬁcantly less
virulent than EMRSA-16 cells that were not exposed to ECg prior
to administration. Incubation with oxacillin after infection had
no impact of survival (circulation: P = 0.5627; yolk: P = 0.6129;
log rank test).
Impact of EMRSA-16 Infection on Immune
Parameters of Zebrafish Embryos
We employed EMRSA-16-GFP in order to visualize bacteria
within 30 hpf embryos following injection into the circulation.
Introduction of the GFP cassette into EMRSA-16 elicited a small
but signiﬁcant increase in embryo survival (data not shown);
therefore, for these experiments an inoculum of 1 × 104 CFU
was employed. At 26 hpi, ﬂuorescent bacteria were visible in the
circulation valley and lining blood vessels. The large majority of
bacteria were found within cells resembling phagocytes. Figure 4
shows typical clusters within granulocyte-like cells of the yolk sac;
large numbers of bacteria were found in this anatomical site after
administration into the circulation. Growth of EMRSA-16-GFP
in ECg-containing E3 medium attenuated the bacteria in similar
fashion to that found with the non-ﬂuorescent parent strain but
no diﬀerences were noted in the distribution of ECg-treated and
untreated ﬂuorescent bacteria over the 70 h observation period.
At 70 hpi, only very few ﬂuorescent bacteria could be detected in
survivors.
Uptake of injected EMRSA-16 by phagocytes suggests that the
embryos mount a partially successful primary innate immune
response to the challenge. We therefore determined the capacity
of embryos to produce reactive oxygen species by measurement
of the NADPH oxidase-dependent respiratory burst following
injection of EMRSA-16 or ECg-grown EMRSA-16 into the
circulation valley (Figure 5). At 1 hpi the response of embryos
infected with ECg-grown EMRSA-16 was signiﬁcantly higher
compared to PBS-injected embryos; in contrast, there was no
signiﬁcant diﬀerence between controls and embryos infected with
untreated EMRSA-16. At 26 hpi, embryos infected with untreated
and ECg-grown bacteria displayed a signiﬁcant response,
although the respiratory burst associated with untreated EMRSA-
16 was weaker than that found with embryos infected with ECg-
exposed EMRSA-16. Sham-injection also induced a relatively
large response but this was not signiﬁcantly diﬀerent from the
untreated control. These associations were less pronounced at
40 hpi and were not evident at 50 hpi. These data suggest
that ECg-grown bacteria were more readily countermanded
by the innate defenses of the embryo, reﬂecting attenuated
virulence following exposure to ECg. However, there were only
small, insigniﬁcant changes in the distribution of the GFP
label following uptake of EMRSA-16-GFP and the ECg-grown
equivalent. Figure 6 shows the distribution of label associated
with 10,000 blood cells at 17 hpi of embryos infected at 30 hpf
with ECg-grown and untreated bacteria.
There were no signiﬁcant diﬀerences in the rate of
transcription of the pro-inﬂammatory cytokine TNF-α as a result
of infection of 30 hpf embryos with either EMRSA-16 or ECg-
grown EMRSA-16 but levels of IL-1β gene expression were
increased following infection (data not shown). At 2 hpi, IL-1β
gene expression increased 2.7-fold and 1.6-fold in EMRSA-16-
infected embryos and embryos infected with ECg-grown bacteria,
compared to sham-treated controls. IL-1β gene expression
in EMRSA-16-infected embryos further increased at 17 hpi,
declining at 43 hpi.
Discussion
Moderate concentrations of ECg substantially and reversibly alter
the phenotype of MRSA isolates, compromising both virulence
and β-lactam resistance without substantial repression of either
the extent or rate of growth in batch culture (Stapleton et al.,
2006). Translation of such in vitro data into eﬃcacy in animal
models of infection has potentially signiﬁcant therapeutic value,
through co-administration of resistance modifying agents with
β-lactam antibiotics that have lost therapeutic utility due to
the emergence of drug resistance. Further, the capacity of ECg
and other catechin gallates to compromise virulence of MRSA
FIGURE 3 | Survival of zebrafish embryos following injection into the circulation valley (A) or yolk sac (B) at 30 hpf with 3 × 103 EMRSA-16 bacteria
modified in vitro by growth in 12.5 μg/mL ECg and incubation in antibiotic-free E3 medium or E3 medium containing 4 μg/mL oxacillin. n = 23–24 per
group; differences between ECg-modified and unmodified bacteria were significant for both injection sites P < 0.001 (log rank test).
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FIGURE 4 | Fluorescence imaging of EMRSA-16-GFP in cells with granulocyte appearance of the yolk sac of zebrafish embryos infected by the
circulation valley at 30 hpf; image obtained 26 h post infection (hpi). Scale bar 10 μm.
suggests that they could be used as stand-alone anti-infective
agents should such attenuation be evident in vivo. Therapeutic
options would be enhanced if chemically stable, “druggable”
analogs with increased potency and enhanced in vivo stability
were available for proﬁling in mammalian models of infection
but, as indicated in the Introduction current technical limitations
to bulk synthesis of analogs of suﬃcient purity make this
impracticable. Zebraﬁsh embryos have been used as a model to
investigate microbe-host interactions (reviewed by Goldsmith
and Jobin, 2012) and fresh insight has been gained into the
basis of host resistance to staphylococcal infection (Prajsnar
et al., 2008). Further, zebraﬁsh and their embryos are now
widely considered as robust tools for drug discovery, drug
development, toxicity proﬁling, and assessment of oﬀ-target drug
eﬀects (Chakraborty et al., 2009; Bowman and Zon, 2010; Strähle
and Grabher, 2010). We therefore adapted the zebraﬁsh embryo
to investigate the capacity of ECg to modify the course of
infection with the multi-drug-resistant epidemic clinical isolate
EMRSA-16.
Zebraﬁsh embryos have a number of attractions for initial low-
cost in vivo proﬁling of therapeutic compounds: high fecundity
and small size allow high throughput studies and the potential
for the generation and storage of very large numbers of adults
and embryos, optical clarity of the embryo permits visualization
of structure in the living embryo, they have well-developed
innate and adaptive immune systems with a high degree of
conservation with mammalian systems and many drugs used
to treat human diseases have comparable eﬀects in embryos.
There are, however, some disadvantages with respect to infection
FIGURE 5 | Induction of the respiratory burst in 30 hpf zebrafish
embryos following infection by the circulation valley with 1 × 104 CFU
EMRSA-16, 1 × 104 CFU ECg-grown EMRSA-16 or PBS sham-injection
control. Embryos were induced with 400 ng/mL of phorbol myristate acetate
in the presence of 1 μg/mL H2DCFDA and the intensity of the fluorescent
signal measured as indicated. n = 10 per group; ∗P < 0.05; log rank test.
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FIGURE 6 | Separation by flow cytometry (10,000 events) of subpopulations of blood cells at 17 hpi from zebrafish embryos infected by the
circulation valley at 30 hpf. Fluorescence reflects uptake by, or association with, GFP-labeled bacteria. (A) Embryos infected with EMRSA-16-GFP and (B), with
ECg-grown EMRSA-16-GFP. Gated populations P1-4 represent erythrocytes, lymphocytes, myelomonocytes, and immature precursors of all lineages. FSC, forward
scatter (size); SSC, side scatter (changes to cell granularity). Blood cell populations identified by comparison with data from Hsu et al. (2004).
with human pathogens such as S. aureus: the optimum growth
temperature range for staphylococci is 35–37◦Cwhereas embryos
must be infected and maintained at 28.5◦C, it is diﬃcult to
dissect embryos for organ recovery for histology and for isolation
of organ-speciﬁc RNA (Aleström et al., 2006), zebraﬁsh do not
possess mammalian organs such as skin, lung, mammary gland,
and prostate (Kari et al., 2007) and their small size requires
the injection of very small amounts of material which may
lead to a high degree of variation between animals. In spite of
these potential drawbacks, dechorionated embryos were readily
infected with EMRSA-16 by injection into the circulation or
yolk. Introduction of the pathogen into the circulation paralleled
infection in mammalian hosts by this route, with a relatively large
dose required to cause death. For example, Xiong et al. (2005)
infected rats intravenously by tail vein injection with 104, 105,
and 106 CFU of S. aureus Xen29; animals dosed with 104 CFU
survived for 6 days, whereas one half infected with 105 CFU died
during this period.Mortality was observed in all rats infected with
106 CFU within 6 days, showing that relatively large numbers
of S. aureus are required to cause death when administered
by this route. In contrast, relatively small numbers of bacteria
(3–5 × 103 CFU) exerted a lethal eﬀect in embryos at or before
70 hpi when injected into the yolk sac at 30 hpf. This may be due
to the physical nature of the yolk, which could hinder detection of
bacteria by the host, whereas injection into the circulation allows
for rapid immune detection of the pathogen.
We have investigated the capacity of ECg to increase the
survival of embryos after EMRSA-16 infection. Green tea, rich in
catechin gallates, is one of the most widely consumed beverages
globally and its components are generally considered benign.
However, there are reports that relatively high concentrations
of ECg and other polyphenols exhibit some degree of toxicity
when they are employed as a nearly pure compound free
from interactions with other chemicals normally found in
green tea extracts (Okabe et al., 1997; Babich et al., 2005); we
therefore limited concentrations of ECg used in our study to
100 μg/mL to ensure that observed eﬀects were unrelated to
any inherent toxicity. Incubation of embryos in E3 medium
containing quantities of ECg suﬃcient to attenuate EMRSA-
16 and to convert bacteria to full β-lactam susceptibility had
no impact on survival, even when oxacillin was incorporated
into the incubation mixture at concentrations suﬃcient to kill
ECg-modiﬁed bacteria in vitro. Further, a range of antibiotics
at concentrations in excess of the MIC also failed to impact on
embryo survival (Stevens and Taylor, unpublished data). The
concentrations of ECg and oxacillin in the incubation mixture
declined signiﬁcantly during the course of these experiments,
suggesting that these compounds may have absorbed to the
surface of the dechorionated embryos but were unable to
penetrate suﬃciently to interact with the pathogen. Bolcome
et al. (2008) indicated that selective inhibitors that work
at nanomolar levels in cell-based assays should be used at
50- to 100-fold higher concentrations in zebraﬁsh embryos
to ensure penetration of the cell layers of the developing
embryo. We therefore incrementally increased the concentration
of ECg to 100 μg/mL, with again no impact on embryo
survival. The permeability of zebraﬁsh membranes has not
been extensively investigated and the available evidence suggests
that the rate of uptake of antibiotics and other compounds
into embryos is highly variable. The chorion and yok sac
are highly impermeable to aqueous solutes (Hagedorn et al.,
1998; Kais et al., 2013), although chloramphenicol, but not
kanamycin, penetrated the outer membrane to gain access to the
internal matrix of dechorionated embryos (Song et al., 2010).
Dechorionated embryos possess a thick outer coating which is
likely to be a formidable barrier to penetration of a variety of
molecules.
The amphipathic nature of catechins and catechin gallates
imposes limits on their capacity to diﬀuse through biomembranes
and other structural barriers. For example, they intercalate into
the membrane of S. aureus and do not enter the cell (Bernal
et al., 2010). It is therefore very plausible that their complete
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lack of eﬃcacy when applied externally to embryos is related to
their inability to cross numerous biological barriers to reach the
staphylococcal target. In addition, the lack of any therapeutic
eﬀect from relatively high concentrations of antibiotics in the
incubation mixture raises doubt over the value of embryos
as tools for the screening of antibiotics, and potentially other
therapeutic molecules. This issue needs further investigation as
zebraﬁsh embryos are ﬁnding increasing favor as an in vivo screen
for new chemical entities.
This study has clearly shown that growth of EMRSA-16
in the presence of ECg produces a less virulent phenotype
with a much lower capacity to elicit a lethal eﬀect, avoid
uptake and killing by phagocytes (as reﬂected in the respiratory
burst) and generate a pro-inﬂammatory response by moderate
induction of IL-1β. Thus, administration of ECg in a way
that enables prolonged and eﬀective contact with the target
pathogen could lead to resolution of the infection. Parenteral
administration of the polyphenol would shed light on this
potential but an alternative to the zebraﬁsh embryo model
would be required. A similar conclusion was reached by Kao
et al. (2010). They grew a drug-susceptible reference strain
of S. aureus in the presence of grape seed extract, a natural
food product rich in polyphenols, and injected the bacteria into
anesthetized adult zebraﬁsh; they noted signiﬁcantly reduced
inﬂammatory responses and mortality compared to bacteria
grown in medium without supplementation. Thus, the zebraﬁsh
model has provided insights into the degree of attenuation
attributable to ECg-mediated interactions in a robust in vivo
model of infection but the capacity to eﬀect this transition within
the infected animal will require further studies in mammalian
models of staphylococcal infection.
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